Fahad A. Al‐Abbasi

5.9k total citations · 1 hit paper
252 papers, 4.3k citations indexed

About

Fahad A. Al‐Abbasi is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Fahad A. Al‐Abbasi has authored 252 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 34 papers in Pharmacology and 28 papers in Complementary and alternative medicine. Recurrent topics in Fahad A. Al‐Abbasi's work include Natural Antidiabetic Agents Studies (15 papers), Phytochemicals and Antioxidant Activities (15 papers) and Curcumin's Biomedical Applications (14 papers). Fahad A. Al‐Abbasi is often cited by papers focused on Natural Antidiabetic Agents Studies (15 papers), Phytochemicals and Antioxidant Activities (15 papers) and Curcumin's Biomedical Applications (14 papers). Fahad A. Al‐Abbasi collaborates with scholars based in Saudi Arabia, India and Egypt. Fahad A. Al‐Abbasi's co-authors include Imran Kazmi, Vikas Kumar, Firoz Anwar, Muhammad Shahid Nadeem, Muhammad Afzal, Mohammad Amjad Kamal, Sami I. Alzarea, Amita Verma, Obaid Afzal and Mahfoozur Rahman and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Fahad A. Al‐Abbasi

237 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

STAT3 Signaling Pathway in Health and Disease

2025 29 citations Md Abdus Samad, Fahad A. Al‐Abbasi et al. MedComm profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fahad A. Al‐Abbasi Saudi Arabia	33	1.6k	455	391	380	356	252	4.3k
Ashraf B. Abdel‐Naim Egypt	37	1.3k 0.8×	540 1.2×	313 0.8×	395 1.0×	436 1.2×	168	4.2k
Keshav Raj Paudel Australia	37	1.7k 1.1×	373 0.8×	331 0.8×	179 0.5×	407 1.1×	206	4.7k
Salman Khan Pakistan	40	1.5k 1.0×	635 1.4×	184 0.5×	314 0.8×	343 1.0×	134	4.3k
Xiaoke Zheng China	31	2.1k 1.3×	416 0.9×	302 0.8×	270 0.7×	375 1.1×	343	4.3k
Shengpeng Wang Macao	35	1.8k 1.1×	541 1.2×	312 0.8×	302 0.8×	533 1.5×	94	3.7k
Rehan Khan India	38	1.4k 0.8×	602 1.3×	187 0.5×	309 0.8×	391 1.1×	138	4.2k
Youwei Xu China	43	2.4k 1.5×	631 1.4×	338 0.9×	267 0.7×	313 0.9×	119	4.4k
Wonhwa Lee South Korea	39	1.7k 1.1×	447 1.0×	212 0.5×	256 0.7×	334 0.9×	155	4.5k
Arshad Husain Rahmani Saudi Arabia	41	1.6k 1.0×	629 1.4×	345 0.9×	394 1.0×	600 1.7×	151	5.1k
Saikat Dewanjee India	42	2.3k 1.4×	483 1.1×	389 1.0×	624 1.6×	459 1.3×	141	6.1k

Countries citing papers authored by Fahad A. Al‐Abbasi

Since Specialization

Citations

This map shows the geographic impact of Fahad A. Al‐Abbasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fahad A. Al‐Abbasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fahad A. Al‐Abbasi more than expected).

Fields of papers citing papers by Fahad A. Al‐Abbasi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fahad A. Al‐Abbasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fahad A. Al‐Abbasi. The network helps show where Fahad A. Al‐Abbasi may publish in the future.

Co-authorship network of co-authors of Fahad A. Al‐Abbasi

This figure shows the co-authorship network connecting the top 25 collaborators of Fahad A. Al‐Abbasi. A scholar is included among the top collaborators of Fahad A. Al‐Abbasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fahad A. Al‐Abbasi. Fahad A. Al‐Abbasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Afzal, Muhammad, et al.. (2025). Exploring acemannan-loaded nanogel formulation for the treatment of IMQ-induced psoriasis-like inflammation: In vitro characterization and in vivo efficacy assessment. International Immunopharmacology. 148. 114064–114064. 4 indexed citations

El‐Halawany, Ali M., et al.. (2025). 6-Paradol enhances sorafenib's effects against colorectal cancer and promotes active metabolite formation. Pathology - Research and Practice. 269. 155876–155876. 1 indexed citations

Baig, Mirza Rafi, et al.. (2025). Evaluation of Cardiovascular and Hepatic Changes in Myocardial Infarction Patients Post-Covid-19 Vaccination. Current Vascular Pharmacology. 23(6). 451–461. 1 indexed citations

Samad, Md Abdus, Mohd Suhail, Torki A. Zughaibi, et al.. (2025). Breast Cancer: Molecular Pathogenesis and Targeted Therapy. MedComm. 6(10). e70404–e70404. 2 indexed citations

Asar, Turky Omar, Fahad A. Al‐Abbasi, Ryan A. Sheikh, et al.. (2024). Metformin’s dual impact on Gut microbiota and cardiovascular health: A comprehensive analysis. Biomedicine & Pharmacotherapy. 178. 117128–117128. 4 indexed citations

Kazmi, Imran, Fahad A. Al‐Abbasi, Ryan A. Sheikh, et al.. (2024). Malvidin attenuates behavioral and inhibits the TNF-α/Caspase-3/Nrf-2 expression in rotenone-induced Parkinson's disease in rats: insights from molecular docking.. PubMed. 28(9). 3330–3346. 2 indexed citations

Al‐Abbasi, Fahad A., et al.. (2024). Fustin alleviates lipopolysaccharide-induced anxiety-depression-like performances by modulation of oxidative stress/neuroinflammatory markers/ NF-κB/caspase-3/BDNF expression in rodents.. PubMed. 28(1). 419–432. 3 indexed citations

Kumar, Vikas, et al.. (2024). Epigenetic Impact of Curcumin and Thymoquinone on Cancer Therapeutics. Current Medicinal Chemistry. 32(11). 2183–2201. 3 indexed citations

Baig, Mirza Rafi, Fahad A. Al‐Abbasi, Sultan Alhayyani, et al.. (2024). Recent Patterns and Assessment of Long-term Complications followi ngSARS-CoV-2 Infection and Vaccination in the Context of Diabet esPrevalence among Blood Donors. Current Diabetes Reviews. 20(9). e110124225520–e110124225520. 2 indexed citations

10.

Beg, Sarwar, Obaid Afzal, Imran Kazmi, et al.. (2023). Natural microbial surfactant containing self-nanoemulsifying formulation with improved performance of paclitaxel therapy: A newer avenue in breast cancer treatment. Journal of Drug Delivery Science and Technology. 90. 105105–105105. 2 indexed citations

11.

Kalaskar, Mohan, Kalpesh R. Patil, Ajay Sharma, et al.. (2023). Volatile Oil Containing Plants as Phytopharmaceuticals to Treat Psoriasis:A Review. Current Pharmaceutical Biotechnology. 25(3). 313–339. 2 indexed citations

12.

Mahdi, Wael A., Shareefa A. AlGhamdi, Syed Sarim Imam, et al.. (2023). Neuroprotectant Effects of Hibiscetin in 3-Nitropropionic Acid-Induced Huntington’s Disease via Subsiding Oxidative Stress and Modulating Monoamine Neurotransmitters in Rats Brain. Molecules. 28(3). 1402–1402. 11 indexed citations

13.

Kazmi, Imran, Muhammad Afzal, Fahad A. Al‐Abbasi, et al.. (2023). Review of the potential pharmacological role of erucic acid: a monounsaturated omega-9 fatty acid. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(6). 3663–3674. 11 indexed citations

14.

Kazmi, Imran, Abdulmalik Saleh Alfawaz Altamimi, Muhammad Afzal, et al.. (2023). Non-coding RNAs: Emerging biomarkers and therapeutic targets in ulcerative colitis. Pathology - Research and Practice. 253. 155037–155037. 5 indexed citations

15.

Alhayyani, Sultan, Abdullah Akhdhar, Amer H. Asseri, et al.. (2023). Potential Anticancer Activity of Juniperus procera and Molecular Docking Models of Active Proteins in Cancer Cells. Molecules. 28(5). 2041–2041. 6 indexed citations

16.

Kamal, Mohammad Amjad, et al.. (2020). Tubulin Proteins in Cancer Resistance: A Review. Current Drug Metabolism. 21(3). 178–185. 25 indexed citations

17.

Shiroorkar, Predeepkumar Narayanappa, Obaid Afzal, Imran Kazmi, et al.. (2020). Cardioprotective Effect of Tangeretin by Inhibiting PTEN/AKT/mTOR Axis in Experimental Sepsis-Induced Myocardial Dysfunction. Molecules. 25(23). 5622–5622. 17 indexed citations

18.

Anwar, Firoz, Hisham N. Altayb, Fahad A. Al‐Abbasi, et al.. (2020). Antiviral effects of probiotic metabolites on COVID-19. Journal of Biomolecular Structure and Dynamics. 39(11). 4175–4184. 108 indexed citations

19.

Afzal, Muhammad, Ruqaiyah Khan, Imran Kazmi, et al.. (2018). Antineoplastic influence of nimesulide in chemically induced hepatocellular carcinoma by inhibition of DNA synthesis. Inflammopharmacology. 27(1). 89–98. 7 indexed citations

20.

Al‐Abd, Ahmed M., et al.. (2015). The chemomodulatory effects of resveratrol and didox on herceptin cytotoxicity in breast cancer cell lines. Scientific Reports. 5(1). 12054–12054. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact